NCT01980303View on ClinicalTrials.gov

A Study to Assess the Pharmacokinetics of Intranasally Administered Esketamine in Healthy Japanese and Caucasian Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions

Healthy Volunteers

Interventions

DRUG

Esketamine

Fourteen percent esketamine solution (14 mg of esketamine per 100 microliter) will be administered intranasally by nasal spray pump.

Trial Locations (1)

Unknown

Cypress

All Listed Sponsors

lead

Janssen Research & Development, LLC

INDUSTRY

NCT01980303 - A Study to Assess the Pharmacokinetics of Intranasally Administered Esketamine in Healthy Japanese and Caucasian Volunteers | Biotech Hunter | Biotech Hunter